Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer

International Journal of Cancer

Volumn 134, Issue 11, 2014, Pages 2656-2662

  Melson, Joshua ^a   Li, Yan ^a   Cassinotti, Elisa ^b   Melnikov, Anatoliy ^c   Boni, Luigi ^b   Ai, Junmei ^a   Greenspan, Michael ^a   Mobarhan, Sohrab ^a   Levenson, Victor ^c   Deng, Youping ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c US Biomarkers Inc   (United States)

Author keywords

biomarkers; cancer screening; colorectal cancer; epigenetics; methylation; pancreatic cancer

Indexed keywords

TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; CYCD2 GENE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DNA METHYLATION; FEMALE; GPC3 GENE; HIC GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MDR1 GENE; MIDDLE AGED; MUC2 GENE; MYF3 GENE; PANCREAS CANCER; PRIORITY JOURNAL; RB1 GENE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SRBC GENE; SYK GENE; TMS GENE; TUMOR GENE; VALIDATION PROCESS; VERY ELDERLY; VHL GENE;

BIOMARKERS; CANCER SCREENING; COLORECTAL CANCER; EPIGENETICS; METHYLATION; PANCREATIC CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896400177     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28593     Document Type: Article

References (44)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the american cancer society, the US multi-society task force on colorectal cancer, and the american college of radiology. Gastroenterology 2008; 134: 1570-95.
3. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. veterans affairs cooperative study group 380. N Engl J Med 2000; 343: 162-8.
4. Canto MI, Hruban RH, Fishman EK, et al. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012; 142: 796-804; quiz e14-5.
5. Kisiel JB, Yab TC, Taylor WR, et al. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer 2012; 118: 2623-31.
6. Liggett T, Melnikov A, Yi QL, et al. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer 2010; 116: 1674-80.
7. Park JW, Baek IH, Kim YT,. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer. Scand J Surg 2012; 101: 38-44.
8. Centers for Disease Control and Prevention (CDC). Cancer screening-United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 61: 41-5.
9. Smith RA, von Eschenbach AC, Wender R, et al. American cancer society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001; 51: 38-75; quiz 77-80.
10. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012; 366: 697-706.
11. Birkenfeld S, Belfer RG, Chared M, et al. Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. J Med Screen 2011; 18: 135-41.
12. Lee JH, Kang MJ, Han HY, et al. Epigenetic alteration of PRKCDBP in colorectal cancers and its implication in tumor cell resistance to TNFalpha-induced apoptosis. Clin Cancer Res 2011; 17: 7551-62.
13. Kim MS, Lee J, Sidransky D,. DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 2010; 29: 181-206.
14. Cassinotti E, Melson J, Liggett T, et al. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. Int J Cancer 2012; 131: 1153-7.
15. Matsubayashi H, Sato N, Fukushima N, et al. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues. Clin Cancer Res 2003; 9: 1446-52.
16. Huang Z, Li L, Wang J,. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci 2007; 52: 2287-91.
17. Ahlquist DA, Taylor WR, Mahoney DW, et al. The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. Clin Gastroenterol Hepatol 2012; 10: 272-7.e1.
18. Ahlquist DA, Sargent DJ, Loprinzi CL, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008; 149: 441-50, W81.
19. Sato N, Fukushima N, Hruban RH, et al. CpG island methylation profile of pancreatic intraepithelial neoplasia. Mod Pathol 2008; 21: 238-44.
20. Bosch LJ, Oort FA, Neerincx M, et al. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res (Phila) 2012; 5: 464-72.
21. Itzkowitz SH, Jandorf L, Brand R,. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007; 5: 111-7.
22. Itzkowitz S, Brand R, Jandorf L, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol 2008; 103: 2862-70.
23. Fukushima N, Walter KM, Uek T, et al. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther 2003; 2: 78-83.
24. deVos T, Tetzner R, Model F, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009; 55: 1337-46.
25. Grutzmann R, Molnar B, Pilarsky C, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008; 3: e3759.
26. Jiao L, Zhu J, Hassan MM, et al. K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking. Pancreas 2007; 34: 55-62.
27. Krop I, Player A, Tablante A, et al. Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res 2004; 2: 489-94.
28. Ahlquist DA, Zou H, Domanico M, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012; 142: 248-56; quiz e25-6.
29. Heichman KA, Warren JD,. DNA methylation biomarkers and their utility for solid cancer diagnostics. Clin Chem Lab Med 2012; 50: 1707-21.
30. Melnikov AA, Scholtens DM, Wiley EL, et al. Array-based multiplex analysis of DNA methylation in breast cancer tissues. J Mol Diagn 2008; 10: 93-101.
31. Melnikov AA, Gartenhaus RB, Levenson AS, et al. MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Res 2005; 33: e93.
32. Melnikov A, Scholtens D, Godwin A, et al. Differential methylation profile of ovarian cancer in tissues and plasma. J Mol Diagn 2009; 11: 60-5.
33. Huang TH, Perry MR, Laux DE,. Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 1999; 8: 459-70.
34. Siegel R, Desantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-41.
35. Zou H, Harrington JJ, Shire AM, et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 2007; 16: 2686-96.
36. Liggett T, Melnikov A, Yi QL, et al. Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer 2010; 116: 1674-80.
37. Warren JD, Xiong W, Bunker AM, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 2011; 9: 133.
38. Grutzmann R, Molnar B, Pilarsky C, et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 2008; 3: e3759.
39. Taback B, Saha S, Hoon DS,. Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients. Ann N Y Acad Sci 2006; 1075: 197-203.
40. Lofton-Day C, Model F, Devos T, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008; 54: 414-23.
41. Fukushima N, Sato N, Ueki T, et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma. Am J Pathol 2002; 160: 1573-81.
42. Gamper AM, Qiao X, Kim J, et al. Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis. Mol Cell 2012; 45: 233-43.
43. Kuwai T, Kitadai Y, Tanaka S, et al. Mutation of the von Hippel-Lindau (VHL) gene in human colorectal carcinoma: association with cytoplasmic accumulation of hypoxia-inducible factor (HIF)-1alpha. Cancer Sci 2004; 95: 149-53.
44. Xu XL, Wu LC, Du F, et al. Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res 2001; 61: 7943-9.